COMPARISON OF SAFETY AND EFFICACY OF ORAL PROGESTERONE WITH LEVONORGESTREL INTRAUTERINE SYSTEM IN MANAGEMENT OF DYSFUNCTIONAL UTERINE BLEEDING

G ANDLEEB; A RASHEED; A MUZAFFAR; SA MALIK

doi:10.54112/bcsrj.v2023i1.313

Authors

G ANDLEEB Department of Obs/Gyn, Nishtar Hospital Multan, Pakistan
A RASHEED Department of Obs/Gyn, THQ Hospital Lyaha, Pakistan
A MUZAFFAR Department of Obs/Gyn, Nishtar Hospital Multan, Pakistan
SA MALIK Department of Obs/Gyn, Latifa Women and Children Hospital Dubai Academic Health Corporation Dubai-UAE

DOI:

https://doi.org/10.54112/bcsrj.v2023i1.313

Keywords:

Dysfunctional Uterine Bleeding, Levonorgestrel Intrauterine System, Oral Progesterone

Abstract

The retrospective study was conducted in the Department of Obstetrics and Gynaecology, Nishtar Medical Hospital, Multan, to compare the safety and efficacy of oral progesterone and levonorgestrel-releasing intrauterine system (LNG-IUS) for the management of DUB. The study was conducted on 90 patients who fulfilled the inclusion criteria. Participants were randomly divided into groups A (LNG-IUS) and B (oral progesterone). The primary outcomes were Pictorial blood loss assessment chart (PBAC) scores. Secondary outcomes were the evaluation of adverse effects and Hb levels. A comparison of the mean PBAC score showed that LNG-IUS significantly reduced PBAC scores (P< 0.0001). Comparison of post-treatment HB levels showed that LNG-IUS significantly increased Hb level, and the difference between both groups was statistically significant (P< 0.0001). After 6 months, the incidence of adverse effects in group B was 60%, while in group A was 40%. However, hypomenorrhea was more prevalent in group A. It can be concluded that LNG-IUS is a more effective and safe treatment choice for Dub compared to oral progesterone.

Downloads

Download data is not yet available.

References

Abbas, A. M., Samy, A., Atwa, K., Ghoneim, H. M., Lotfy, M., Saber Mohammed, H., Abdellah, A. M., El Bahie, A. M., Aboelroose, A. A., and El Gedawy, A. M. (2020). The role of levonorgestrel intra‐uterine system in the management of adenomyosis: A systematic review and meta‐analysis of prospective studies. Acta obstetricia et gynecologica Scandinavica 99, 571-581.

Bafna, B. A., and Bafna, A. N. (2021). Levonorgestrel intrauterine system in menorrhagia-an effective and acceptable alternative. International Journal of Reproduction, Contraception, Obstetrics and Gynecology 10, 1665-1671.

Beelen, P., van den Brink, M. J., Herman, M. C., Geomini, P. M., Dekker, J. H., Duijnhoven, R. G., Mak, N., van Meurs, H. S., Coppus, S. F., and van der Steeg, J. W. (2021). Levonorgestrel-releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding. American journal of obstetrics and gynecology 224, 187. e1-187. e10.

Cooper, K., Breeman, S., Scott, N. W., Scotland, G., Clark, J., Hawe, J., Hawthorn, R., Phillips, K., MacLennan, G., and Wileman, S. (2019). Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial. The Lancet 394, 1425-1436.

Depes, D. D. B., Mata, M. V. M. d., Pereira, A. M. G., Martins, J. A., Araújo, M. P. d., Lopes, R. G. C., and Bella, Z. I. K. d. J.-D. (2023). Comparative study of the levonorgestrel intrauterine system and laparoscopic hysterectomy for the treatment of heavy menstrual bleeding in enlarged uteri. einstein (São Paulo) 21, eAO0033.

Gök, S., Alataş, E., and ALATAŞ, E. (2022). Effects of Levonorgestrel-Releasing Intrauterine Device Therapy on Ovarian Reserve in Menorrhagia. Cureus 14.

Guerin, J., Engelmann, A., Mattamana, M., and Borgelt, L. M. (2022). Use of hormonal contraceptives in perimenopause: a systematic review. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 42, 154-164.

Joo, J.-K., Shin, J.-H., Lee, J. R., and Kim, M.-R. (2021). Levonorgestrel-releasing intrauterine system use in perimenopausal women. Journal of menopausal medicine 27, 49.

Kaitala, S., Suvidha, N., and Lakshmi, K. N. V. A Prospective Study on the Efficacy of Levonorgestrel-Releasing Intrauterine Device in Abnormal Uterine Bleeding.

Kumari, A., Tirkey, S., and Prakash, J. (2022). Effectiveness of Levonorgestrel Releasing Intrauterine System in Perimenopausal Women with Heavy Menstrual Bleeding: A Prospective Study at a Teaching Hospital in India. Journal of Menopausal Medicine 28, 128-135.

Malik, F., Sara, S., and Kasi, R. (2020). Comparative trial of levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. Pakistan J Medical Health Sci 14, 1184-6.

Momoeda, M., Akira, S., Harada, T., Kitawaki, J., Maeda, N., Ota, I., Yoshihara, K., and Takahashi, N. (2022). Quality of life of Japanese dysmenorrhea/heavy menstrual bleeding patients treated with levonorgestrel intrauterine delivery system in a real-world setting. Advances in Therapy 39, 3616-3634.

Otgontuya, A., Jeng, C.-J., Wu, T.-N., Chuang, L. T., and Shen, J. (2023). Comparison of the treatment efficacies of HIFU, HIFU combined with GnRH-a, and HIFU combined with GnRH-a and LNG-IUS for adenomyosis: A systematic review and meta-analysis. Taiwanese Journal of Obstetrics and Gynecology 62, 226-238.

Reid, P. C., Coker, A., and Coltart, R. (2000). assessment of menstrual blood loss using a pictorial chart: a validation study. BJOG: An International Journal of Obstetrics & Gynaecology 107, 320-322.

Schoep, M. E., Nieboer, T. E., van der Zanden, M., Braat, D. D., and Nap, A. W. (2019). The impact of menstrual symptoms on everyday life: a survey among 42,879 women. American journal of obstetrics and gynecology 220, 569. e1-569. e7.

Somasundar, B. M., and Shanmugam, L. (2022). Comparative Study of Histopathology of Hysterectomy Specimen with Dilatation and Curettage and Hysteroscopic-guided Biopsy in Evaluating Perimenopausal and Postmenopausal Bleeding. Journal of South Asian Federation of Obstetrics and Gynaecology 14, 527-530.